Intas and IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
The Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ENV-6946 in healthy volunteers
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Subscribe To Our Newsletter & Stay Updated